Characterization of the lipid profile in dementia and depression in the elderly

Journal of Geriatric Psychiatry and Neurology

Volumn 20, Issue 3, 2007, Pages 138-144

  Dimopoulos, Nikolaos ^a   Piperi, Christina ^a   Salonicioti, Aristea ^b   Psarra, Vassiliki ^c   Mitsonis, Charalampos ^c   Liappas, Ioannis ^d   Lea, Robert W ^e   Kalofoutis, Anastasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Health Center   (Greece)

^c Psychiatric Hospital of Athens   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Dementia; Depression; Elderly; Lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; GERIATRIC DEPRESSION SCALE; GREECE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PATIENT ASSESSMENT; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGING; CHOLESTEROL; CHOLESTEROL, HDL; COGNITION; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; GERIATRIC ASSESSMENT; GREECE; HUMANS; LIPIDS; MALE; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TRIGLYCERIDES;

EID: 34547824158     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988707301867     Document Type: Article

References (49)

1. Hofman A., Rocca WA, Brayne C. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol. 1991 ; 20: 736-748.
2. Ritchie K., Kildea D. Is senile dementia age-related ar ageing-related? Evidence from a meta-analysis of dementia prevalence in the oldest-old. Lancet. 1995 ; 346: 931-934.
3. Skoog I., Nilsson L., Palmertz B., Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Eng J Med. 1993 ; 328: 153-158.
4. Jorm A., Korten AE, Henderson AS The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987 ; 76: 465-479.
5. Lebowitz B., Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA. 1997 ; 278: 1186-1190.
6. Doody R., Stevens JC, Beck C., et al. Practice parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 ; 56: 1154-1166.
7. Hofman A., Ott A., Breteler Mmb, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997 ; 349: 151-154.
8. Kivipelto M., Helkala EL, Hanninen T., et al. Midlife vascular risk factors and late-life mild cognitive impairment. A population-based study. Neurology. 2001 ; 56: 1683-1689.
9. Simons M., Keller P., Dichgans J., Schulz JB Cholesterol and Alzheimer's disease. Is there a link? Neurology. 2001 ; 57: 1089-1093.
10. Tan Z., Seshadri S., Beiser A., et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003 ; 163: 1053-1057.
11. Caramelli P., Nitrini R., Maranhao R., et al. Increase apolipoprotin B serum concentration in Alzheimer's disease. Acta Neurol Scand. 1999 ; 100: 61-63.
12. Moroney J., Tang MX, Berglund L., et al. Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke. JAMA. 1999 ; 282: 254-260.
13. Morgan R., Palinkas LA, Barret-Connel EL, Wingard DL Plasma cholesterol and depressive symptoms in older men. Lancet. 1993 ; 341: 75-79.
14. Aijanseppa S., Kivinen P., Helkala EL, Kivela SL, Tuomilehto J., Nissinen A. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry. 2002 ; 17: 629-634.
15. Stewart R., Sharples KJ, North FM, Menkes DB, Baker J., Simes J. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Arch Intern Med. 2000 ; 160: 3144-3152.
16. Ergun U., Uguz S., Bozdemir N., et al. The relationship between cholesterol levels and depression in the elderly. Int J Geriatr Psychiatry. 2004 ; 19: 291-296.
17. Vertesi A., Lever JA, Molloy DW, et al. Standardized mini-mental state examination; use and interpretation. Can Fam Phys. 2001 ; 47: 2018-2023.
18. Sajatovic M., Ramirez L. Geriatric Depression Scale (GDS). In: Sajatovic M, Ramirez L, ed. Rating Scales in Mental Health. Hudson, Oh: Lexi-Comp, Inc. ; 2003: 405-406.
19. Rapp S., Walsh DA, Parisi SA, Wallace CE Detecting depression in elderly medical inpatients. J Consult Clin Psychol. 1998 ; 56: 509-513.
20. Iliffe S., Haines A., Gallivan S., Booroff A., Goldenberg E., Morgan P. Assessment of elderly people in general practice. Br J Gen Pract. 1991 ; 41: 9-15.
21. Blazer D. Depression in the elderly: myths and misconceptions. Psychiatr Clin North Am. 1997 ; 20: 111-119.
22. Gorelick P. Risk factors for vascular dementia and Alzheimer's disease. Stroke. 2004 ; 35: 2620-2622.
23. Stern Y., Alexander GE, Prohovnik I., Mayeux R. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol. 1992 ; 32: 371-375.
24. Evans R., Emsley MS, Gao S., et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans. Neurology. 2000 ; 54: 240.
25. Pappolla M., Bryant-Thomas TK, Herbert D., et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003 ; 61: 199-205.
26. Henderson V., Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry. 2003 ; 74: 1530-1535.
27. Schalk B., Visser M., Deeg DJ, Bouter LM Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing. 2004 ; 33: 266-272.
28. Zuliani G., Ble A., Zanca R., et al. Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriatr. 2001 ; 1: 5.
29. van Exel E., de Craen AJ, Gussekloo J., et al. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol. 2002 ; 51: 716-721.
30. Reitz C., Tang MX, Luchsinger J., Mayeux R. Relation of plasma lipids to Alzheimer's disease and vascular dementia. Arch Neurol. 2004 ; 61: 705-714.
31. Dietschy J., Turley SD Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001 ; 12: 105-112.
32. Brown S., Salive ME, Harris TB, Simonsick EM, Guralnik JM, Kohout FJ Low cholesterol concentrations and severe depressive symptoms in elderly people. Br Med J. 1994 ; 308: 1328-1332.
33. Partonen T., Haukka J., Virtamo J., Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999 ; 175: 259-262.
34. Terao T., Iwata N., Kanazawa K., et al. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr Scand. 2000 ; 101: 231-234.
35. Nakao M., Yano E. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med. 2004 ; 204: 273-287.
36. Alexopoulos G., Meyers BS, Young RC, Kakuma T., Silbersweig D., Charlson M. Clinically defined vascular depression. Am J Psychiatry. 1997 ; 154: 562-565.
37. Krishnan K., Hays JC, Blazer DG MRI-defined vascular depression. Am J Psychiatry. 1997 ; 154: 497-501.
38. Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet. 2004 ; 363: 1139-1146.
39. Ritchie K., Lovestone S. The dementias. Lancet. 2002 ; 360: 1759-1766.
40. Wolozin B., Kellman W., Ruosseau P., Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000 ; 57: 1439-1443.
41. Pappolla M., Bryant-Thomas TK, Herbert D., et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003 ; 61: 199-205.
42. Refolo L., Pappolla MA, Malester B., et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis. 2000 ; 7: 321-331.
43. Park IH, Hwang EM, Hong HS, et al. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging. 2003 ; 24: 637-643.
44. Porter FD RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab. 2000 ; 71: 163-174.
45. Greeve I., Hermans-Borgmeyer I., Brellinger C., et al. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci. 2000 ; 20: 7345-7352.
46. Ledesma MD, Abad-Rodriguez J., Galvan C., et al. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep. 2003 ; 4: 1190-1196.
47. Abad-Rodriguez J., Ledesma MD, Craessaerts K., et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol. 2004: 6 ; 167: 809-812.
48. Ledesma MD, Dotti CG The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. Biochem Soc Symp. 2005 ; 72: 129-138.
49. Strittmatter W., Roses AD Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci. 1996 ; 19: 53-77.